ArticleJournal of hematology & oncology2021

Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.

Yangyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.